Live
PharmaVoiceThe biotech market is rebounding. So where are the executive jobs?FierceBiotechSoligenix axes lymphoma program after phase 3 setback, mulls M&A optionsFierceBiotechBeyond Rigid Platforms: Adaptive Adenoviral Platform De-Risks Development to GMPFierceBiotechHow NEC's AI and oral delivery system are redefining personalized cancer therapyEndpoints NewsLilly puts its stamp at #EHA26 with Jaypirca combo data in CLL, first clinical data from Ajax buyoutBioPharma DiveCeliac disease is entering a new era of therapeutic innovationBioPharma DivePlanning a successful pivot from lab to clinicEndpoints NewsHMNC Brain Health raises $50M Series B to advance two depression drugseLifeExposure to false cardiac feedback alters pain perception and anticipatory cardiac frequencyeLifeNuclear CK1δ as a critical determinant of PER:CRY complex dynamics and circadian periodJIANGSU KANGJIAN MEDICAL APPARATUS CO.,LTD.World Cryo-Preservation Vial System - Market Analysis, Forecast, Size, Trends and Insights - IndexBoxBioWorldViva in vivo! At EHA, in vivo CAR T data continues to impress
WuXi Biologics 25 avr. 2026

WuXi Biologics Secures MFDS GMP Certification For Three Key Manufacturing Facilities - BioPharma APAC

WuXi Biologics Secures MFDS GMP Certification For Three Key Manufacturing Facilities - BioPharma APAC

Contenu indisponible. Consultez la source originale.